Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-060549

VP, Chief Accounting Officer gave up 191 shares (to pay taxes)

  • VP, Chief Accounting Officer acquired 552 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Peraza Lisa VP, Chief Accounting Officer 2021-10-13 Option exercise +552 14,388 D
Peraza Lisa VP, Chief Accounting Officer 2021-10-13 Shares withheld for taxes −191 $10.55 $2,015 14,197 D
Derivatives
Peraza Lisa VP, Chief Accounting Officer 2021-10-13 Option exercise · Restricted Stock Units −552 6,625 D
Peraza Lisa VP, Chief Accounting Officer 2021-10-13 Grant or award · Employee Stock Option (Right to Buy) +13,013 13,013 D
Peraza Lisa VP, Chief Accounting Officer 2021-10-13 Grant or award · Restricted Stock Units +23,424 23,424 D
Loading xslF345X03/doc4.xml…